These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24981871)

  • 21. The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.
    Steinfurt J; Biermann J; Bode C; Odening KE
    Dtsch Arztebl Int; 2015 Jun; 112(23):394-401. PubMed ID: 26157012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E;
    Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.
    Sacher F; Probst V; Iesaka Y; Jacon P; Laborderie J; Mizon-Gérard F; Mabo P; Reuter S; Lamaison D; Takahashi Y; O'Neill MD; Garrigue S; Pierre B; Jaïs P; Pasquié JL; Hocini M; Salvador-Mazenq M; Nogami A; Amiel A; Defaye P; Bordachar P; Boveda S; Maury P; Klug D; Babuty D; Haïssaguerre M; Mansourati J; Clémenty J; Le Marec H
    Circulation; 2006 Nov; 114(22):2317-24. PubMed ID: 17116772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of class-I antiarrhythmic drug test in the evaluation of patients with syncope: unmasking Brugada syndrome.
    Roos M; Sarkozy A; Brodbeck J; Henkens S; Chierchia GB; de Asmundis C; Capulzini L; Müller-Burri SA; Yakazi Y; Brugada P
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):290-5. PubMed ID: 21985403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.
    Kawabata M; Goya M; Sasaki T; Maeda S; Yagishita A; Shirai Y; Kaneko M; Shiohira S; Isobe M; Hirao K
    Circ J; 2017 Jun; 81(7):981-987. PubMed ID: 28367844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis.
    Sieira J; Ciconte G; Conte G; Chierchia GB; de Asmundis C; Baltogiannis G; Di Giovanni G; Saitoh Y; Irfan G; Casado-Arroyo R; Julià J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1144-50. PubMed ID: 26215662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P; Faria B; Dias G; Cardoso F; Alves MJ; Alves A; Rodrigues B; Ribeiro S; Sanfins V; Lourenço A
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):33-38. PubMed ID: 33436324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline　- A Multicenter Validation Study.
    Wakamiya A; Kamakura T; Shinohara T; Yodogawa K; Murakoshi N; Morita H; Takahashi N; Inden Y; Shimizu W; Nogami A; Horie M; Nakajima K; Kataoka N; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Yasuda S; Ieda M; Kusano K
    Circ J; 2020 Nov; 84(12):2158-2165. PubMed ID: 33071242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of patients with the Brugada type 1 electrocardiogram without prophylactic implantable cardioverter defibrillator in primary prevention: a cumulative analysis of seven large prospective studies.
    Delise P; Probst V; Allocca G; Sitta N; Sciarra L; Brugada J; Kamakura S; Takagi M; Giustetto C; Calo L
    Europace; 2018 Jun; 20(FI1):f77-f85. PubMed ID: 29036426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognosis of drug-induced Brugada syndrome.
    Sieira J; Ciconte G; Conte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; Saitoh Y; Casado-Arroyo R; Juliá J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Heart Rhythm; 2017 Oct; 14(10):1427-1433. PubMed ID: 28479512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unsafe Drug Use and Arrhythmic Events in Brugada Patients with ICD: Results of a Long-Term Follow-Up.
    de Almeida Fernandes D; António N; Madeira M; Sousa P; Ventura M; Cristóvão J; Nascimento J; Elvas L; Gonçalves L; Pego GM
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):23-28. PubMed ID: 29372449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
    Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
    Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Tachibana M; Nishii N; Morita H; Nakagawa K; Watanabe A; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1454-1459. PubMed ID: 28800177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients.
    Milman A; Gourraud JB; Andorin A; Postema PG; Sacher F; Mabo P; Conte G; Giustetto C; Sarquella-Brugada G; Hochstadt A; Kim SH; Juang JJM; Maeda S; Takahashi Y; Kamakura T; Aiba T; Leshem E; Michowitz Y; Rahkovich M; Mizusawa Y; Arbelo E; Huang Z; Denjoy I; Wijeyeratne YD; Napolitano C; Brugada R; Casado-Arroyo R; Champagne J; Calo L; Tfelt-Hansen J; Priori SG; Takagi M; Veltmann C; Delise P; Corrado D; Behr ER; Gaita F; Yan GX; Brugada J; Leenhardt A; Wilde AAM; Brugada P; Kusano KF; Hirao K; Nam GB; Probst V; Belhassen B
    Heart Rhythm; 2018 Oct; 15(10):1457-1465. PubMed ID: 29908370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The electrophysiological study and implantable cardioverter defibrillator therapy for the patients with Brugada syndrome].
    Shan QJ; Yang B; Chen ML; Zou JG; Xu DJ; Chen C; Li KL; Zhu PJ; Wang XB; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):34-6. PubMed ID: 15924775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.